PortfoliosLab logoPortfoliosLab logo
CVKD vs. DAL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CVKD vs. DAL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cadrenal Therapeutics Inc. Common Stock (CVKD) and Delta Air Lines, Inc. (DAL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CVKD achieves a -70.35% return, which is significantly lower than DAL's 26.98% return.


CVKD

1D
-3.83%
1M
-44.17%
6M
-71.08%
YTD
-70.35%
1Y
-80.54%
3Y*
-46.42%
5Y*
10Y*
ALL TIME*
-65.49%

DAL

1D
-1.30%
1M
-5.49%
6M
33.75%
YTD
26.98%
1Y
72.81%
3Y*
25.80%
5Y*
17.82%
10Y*
10.53%
ALL TIME*
8.36%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$110.41K$169.96K$278.30K
$513.87M$597.15M$617.50M

CVKD vs. DAL - Yearly Performance Comparison


2026 (YTD)202520242023
CVKD
Cadrenal Therapeutics Inc. Common Stock
-70.35%-53.21%30.56%-87.04%
DAL
Delta Air Lines, Inc.
26.98%16.09%52.00%5.42%

Correlation

The correlation between CVKD and DAL is 0.13, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.13

Correlation (3Y)
Balances recent behavior with more history.

0.17

Correlation (All Time)
Calculated using the full available price history since Jan 20, 2023

0.17

Fundamentals

Market Cap

CVKD:

$6.23M

DAL:

$57.50B

EPS

CVKD:

-$5.05

DAL:

$6.04

PB Ratio

CVKD:

1.46

DAL:

2.63

Total Revenue (TTM)

CVKD:

$0.00

DAL:

$68.29B

Gross Profit (TTM)

CVKD:

-$5.92K

DAL:

$18.66B

EBITDA (TTM)

CVKD:

-$13.32M

DAL:

$8.42B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CVKD vs. DAL — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CVKD
CVKD Risk / Return Rank: 66
Overall Rank
CVKD Sharpe Ratio Rank: 99
Sharpe Ratio Rank
CVKD Sortino Ratio Rank: 55
Sortino Ratio Rank
CVKD Omega Ratio Rank: 77
Omega Ratio Rank
CVKD Calmar Ratio Rank: 66
Calmar Ratio Rank
CVKD Martin Ratio Rank: 44
Martin Ratio Rank

DAL
DAL Risk / Return Rank: 8686
Overall Rank
DAL Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
DAL Sortino Ratio Rank: 8787
Sortino Ratio Rank
DAL Omega Ratio Rank: 8282
Omega Ratio Rank
DAL Calmar Ratio Rank: 8686
Calmar Ratio Rank
DAL Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CVKD vs. DAL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cadrenal Therapeutics Inc. Common Stock (CVKD) and Delta Air Lines, Inc. (DAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CVKDDALDifference
Sharpe ratioReturn per unit of total volatility

-2.46

Sortino ratioReturn per unit of downside risk

-4.08

Omega ratioGain probability vs. loss probability

0.82

1.28

-0.45

Calmar ratioReturn relative to maximum drawdown

-0.94

2.90

-3.84

Martin ratioReturn relative to average drawdown

-1.61

9.15

-10.76

CVKD vs. DAL - Sharpe Ratio Comparison

The current CVKD Sharpe Ratio is -0.80, which is lower than the DAL Sharpe Ratio of 1.66. The chart below compares the historical Sharpe Ratios of CVKD and DAL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CVKD vs. DAL - Drawdown Comparison

The maximum CVKD drawdown since its inception was -97.70%, which is greater than DAL's maximum drawdown of -81.93%. Use the drawdown chart below to compare losses from any high point for CVKD and DAL.


Loading charts...

Drawdown Indicators


CVKDDALDifference

Max Drawdown

Largest peak-to-trough decline

-97.70%

-81.93%

-15.77%

Max Drawdown (1Y)

Largest decline over 1 year

-86.13%

-22.90%

-63.23%

Max Drawdown (3Y)

Largest decline over 3 years

-92.78%

-47.92%

-44.86%

Max Drawdown (5Y)

Largest decline over 5 years

-47.92%

Max Drawdown (10Y)

Largest decline over 10 years

-69.18%

Current Drawdown

Current decline from peak

-97.65%

-6.41%

-91.24%

Average Drawdown

Average peak-to-trough decline

-85.16%

-28.95%

-56.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

50.14%

7.26%

+42.88%

Volatility

CVKD vs. DAL - Volatility Comparison

Cadrenal Therapeutics Inc. Common Stock (CVKD) has a higher volatility of 26.48% compared to Delta Air Lines, Inc. (DAL) at 9.59%. This indicates that CVKD's price experiences larger fluctuations and is considered to be riskier than DAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CVKDDALDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.48%

9.59%

+16.89%

Volatility (6M)

Calculated over the trailing 6-month period

70.68%

30.38%

+40.30%

Volatility (1Y)

Calculated over the trailing 1-year period

100.94%

40.13%

+60.81%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

101.96%

40.93%

+61.03%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

101.96%

42.08%

+59.88%

Dividends

CVKD vs. DAL - Dividend Comparison

CVKD has not paid dividends to shareholders, while DAL's dividend yield for the trailing twelve months is around 0.89%.


PositionTTM20252024202320222021202020192018201720162015
CVKD
Cadrenal Therapeutics Inc. Common Stock
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DAL
Delta Air Lines, Inc.
0.89%0.97%0.83%0.50%0.00%0.00%1.00%2.57%2.63%1.81%1.37%0.89%

Financials

CVKD vs. DAL - Financials Comparison

This section allows you to compare key financial metrics between Cadrenal Therapeutics Inc. Common Stock and Delta Air Lines, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


CVKD and DAL have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CVKD has higher volatility (26.48%) compared to DAL (9.59%). In terms of maximum drawdown, CVKD dropped -97.70% vs DAL's -81.93%.

DAL currently has the higher Sharpe Ratio (1.66 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CVKD and DAL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer